ACM Research, Inc.
For the period ended Sep 30, 2026. Filed Nov 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On August 17, 2026, Charles Pappis, Board Member of ACM Research, Inc., adopted a Rule 10b5-1 trading arrangement (the “Pappis Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The Pappis Plan allows for the contemporaneous exercise of options and sale of up to 20,000 shares of Class A Common Stock, at specific market prices, commencing on November 16, 2026, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii)August 17, 2027, or (iii) such date that the Pappis Plan is otherwise terminated according to its terms, whichever comes first.
On September 4, 2026, Tracy Liu, Board Member of ACM Research, Inc. adopted a Rule 10b5-1 trading arrangement (the “Liu Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The Liu Plan allows for the contemporaneous exercise of options and sale of up to 19,500 shares of Class A Common Stock, at specific market prices, commencing on January 4, 2027, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii)December 31, 2027, or (iii) such date that the Liu Plan is otherwise terminated according to its terms, whichever comes first.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.